qingfei chu

Ms. qingfei chu

The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2024 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
QCqingfei chu
qingfei chu
XZXuelian Zhou
Xuelian Zhou
QCQingfei Chu
Qingfei Chu

8 September 2024 in Clinical and Translational Medicine
Verified
Journal Article
Open access
DCDi Chen
Di Chen
LXLixia Xu
Lixia Xu
MXMengjuan Xuan
Mengjuan Xuan
QCqingfei chu
qingfei chu
CXChen Xue
Chen Xue
Recent studies have established the pivotal roles of patient‐derived tumour organoids (PDTOs), innovative three‐dimensional (3D) culture systems, in various biological and medical applications. PDTOs, as promising tools, have been established and extensively used for drug screening, prediction of immune response and assessment of immunotherapeutic effectiveness in various cancer types, including glioma, ovarian cancer and so on. The overarching goal is to facilitate the translation of new therapeutic modalities to guide personalised immunotherapy. Notably, there has been a recent surge of interest in the co‐culture of PDTOs with immune cells to investigate the dynamic interactions between tumour cells and immune microenvironment. A comprehensive and in‐depth investigation is necessary to enhance our understanding of PDTOs as promising testing platforms for cancer immunotherapy. This review mainly focuses on the latest updates on the applications and challenges of PDTO‐based methods in anti‐cancer immune responses. We strive to provide a comprehensive understanding of the potential and prospects of PDTO‐based technologies as next‐generation strategies for advancing immunotherapy approaches.

14 June 2024 in Viruses
Verified
Journal Article
Open access
PDF file
ARAbdur Rashid
Abdur Rashid
LKLi Kang
Li Kang
FYFeng Yi
Feng Yi
QCqingfei chu
qingfei chu
SSSharaf Ali Shah
Sharaf Ali Shah
YSYiming Shao
Yiming Shao
The human immunodeficiency virus type-1 epidemic in Pakistan has significantly increased over the last two decades. In Karachi, Pakistan, there is a lack of updated information on the complexity of HIV-1 genetic diversity and the burden of drug resistance mutations (DRMs) that can contribute to ART failure and poor treatment outcomes. This study aimed to determine HIV-1 genetic diversity and identify drug-resistance mutations among people living with HIV in Karachi. A total of 364 HIV-positive individuals, with a median age of 36 years, were enrolled in the study. The HIV-1 partial pol gene was successfully sequenced from 268 individuals. The sequences were used to generate phylogenetic trees to determine clade diversity and also to assess the burden of DRMs. Based on the partial pol sequences, 13 distinct HIV-1 subtypes and recombinant forms were identified. Subtype A1 was the most common clade (40%), followed by CRF02_AG (33.2%). Acquired DRMs were found in 30.6% of the ART-experienced patients, of whom 70.7%, 20.7%, and 8.5% were associated with resistance to NNRTIs, NRTIs, and PIs, respectively. Transmitted DRMs were found in 5.6% of the ART-naïve patients, of whom 93% were associated with resistance against NNRTIs and 7% to PIs. The high prevalence of DRMs in ART-experienced patients poses significant challenges to the long-term benefits and sustainability of the ART program. This study emphasizes the importance of continuous HIV molecular epidemiology and drug resistance surveillance to support evidence-based HIV prevention, precise ART, and targeted AIDS care.

13 October 2025 in Clinical and Translational Medicine
Verified
Journal Article
Open access
QCqingfei chu
qingfei chu
NFNingye Fang
Ningye Fang
HCHuanhuan Chen
Huanhuan Chen
ARAbdur Rashid
Abdur Rashid
XLXia Luo
Xia Luo
KLKang Li
Kang Li
Background: A subset of people living with HIV (PLWH) exhibit poor immune recovery despite effective antiretroviral therapy (ART), remaining at risk of disease progression. The immunometabolic mechanisms underlying this immunological non‐response remain unclear. Methods: We integrated transcriptomic and immunophenotypic approaches to characterise immune differences between immunological responders (IRs) and non‐responders (INRs). Public datasets were analysed to identify differentially expressed genes (DEGs), followed by enrichment analysis, predictive modelling, immune infiltration assessment, and regulatory network construction. In parallel, flow cytometry was performed to assess T and B cell subsets in an independent cohort including IRs, INRs, treatment‐naïve patients (TNPs), and healthy controls (HCs). Results: DEGs between IRs and INRs were enriched in mitochondrial and ribosomal pathways. INRs showed reduced Th1, Th17, and Tfh cells, alongside increased markers of immune activation and exhaustion. Predictive modelling identified five hub genes ( ATP5O, PIGY, UQCRQ, COX7C , and BLVRB ) associated with immune recovery, and clustering based on their expression defined two transcriptionally distinct subtypes. Flow cytometry further confirmed that INRs exhibited diminished CD4⁺ T cell counts, increased PD‐1⁺ and HLA‐DR⁺ expression, and reduced resting memory B cells, reflecting persistent immune dysfunction. Conclusions: This study underscores the pivotal role of immunometabolic dysregulation in shaping heterogeneous immune responses to ART. By integrating computational and experimental data, we identified key biomarkers and regulatory pathways associated with immune recovery. Our findings highlight the central influence of metabolic processes on immune restoration outcomes and propose personalised metabolic interventions as a promising strategy to enhance therapeutic efficacy in HIV‐infected individuals.

28 October 2026 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
LLLiang Liu
Liang Liu
WZWanying Zhang
Wanying Zhang
QCqingfei chu
qingfei chu
Background: Clinical supervision and access to learning opportunities are associated dimensions of the clinical learning environment. Their associations with perceived placement experience are relevant to organizational review of educational quality. This study examined associations among three National Education and Training Survey (NETS) 2025 indicators using a workplace learning affordances perspective. Methods: We analyzed public organization-level aggregate scores from the NETS 2025 reporting tool. An extraction audit during revision corrected incomplete pagination and compressed-value decoding errors in the initial extract. The corrected dataset included 743 reporting organizations with complete Supervision, Teaching & Learning, and Overall Experience scores. Ordinary least squares models used HC3 robust standard errors. A theory-informed statistical decomposition estimated an indirect association, with percentile confidence intervals from 10,000 organization-level bootstrap resamples. Sensitivity analyses examined boundary scores, influential observations, additional indicators, respondent-count weighting, minimum respondent counts, and clustering. Results: Supervision was positively associated with Overall Experience (B = 0.838, 95% CI 0.794–0.883) and Teaching & Learning (B = 0.789, 95% CI 0.742–0.835). Teaching & Learning remained associated with Overall Experience after adjustment for Supervision (B = 0.375, 95% CI 0.306–0.443). The indirect association was 0.295 (bootstrap 95% CI 0.240–0.351), or 0.314 after standardization (95% CI 0.258–0.367). The outcome model had R 2 = 0.837 and adjusted R 2 = 0.836. Sensitivity estimates remained positive but varied in magnitude. Conclusions: Organizations with higher supervision scores also had higher perceived teaching and learning quality and overall experience scores. The cross-sectional decomposition identifies a positive indirect component whose magnitude varies across specifications. These findings support reviewing supervision, access to learning opportunities, and overall experience as a connected profile when interpreting organizational survey feedback. These organization-level associations do not establish individual-level effects or causal mediation.